ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #3,040Hybrid

Journal of Neurotrauma

Abbreviation (ISO):J NEUROTRAUM
•
Identifier (ISSN):0897-7151(Print)/1557-9042(Online)
•
Publisher:Mary Ann Liebert Inc.
Clarivate IF (2026)
3.8– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Neurotrauma

WoS Q2
2457520183.7520193.7920205.2720214.8720224.220233.920243.820253.82026
Annual Impact Factor Metric
Current (2026):3.8
Scopus SJR & RankScopus Q1
1.329
#3,040

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
187

187 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate7.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
233articles/year
13.09% Gold OA•86.24% Original Research

Aims & Scope

Journal of Neurotrauma is the flagship, peer-reviewed publication for reporting on the latest advances in both the clinical and laboratory investigation of traumatic brain and spinal cord injury. The Journal focuses on the basic pathobiology of injury to the central nervous system, while considering preclinical and clinical trials targeted at improving both the early management and long-term care and recovery of traumatically injured patients. This is the essential journal publishing cutting-edge basic and translational research in traumatically injured human and animal studies, with emphasis on neurodegenerative disease research linked to CNS trauma.

Topics Covered (Recognized by AI)
Medicine99.4%Psychology94.7%Biology87.2%Psychiatry84.9%Internal medicine76.5%Neuroscience70.4%Traumatic brain injury53.7%Pathology47.6%Endocrinology44.1%Surgery42.9%Anesthesia42.3%Chemistry41.5%Biochemistry38%Genetics37.4%Radiology28.1%Spinal cord24.6%Spinal cord injury22.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CLINICAL NEUROLOGY

Q2
Rank80/296
IndexSCIE
JCRSCIE2026

CRITICAL CARE MEDICINE

Q2
Rank19/66
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q2
Rank118/330
IndexSCIE
JCISCIE2026

CLINICAL NEUROLOGY

Q2
Rank81/296
IndexSCIE
JCISCIE2026

CRITICAL CARE MEDICINE

Q2
Rank17/66
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q2
Rank101/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.8
Articles / Year148
Total Citations49
2025
IF3.8
Articles / Year180
Total Citations534
2024
IF3.9
Articles / Year176
Total Citations1,159
2023
IF4.2
Articles / Year204
Total Citations2,568
2022
IF4.869
Articles / Year234
Total Citations3,802

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,040Scopus Q1SCImago Profile
Scopus Coverage:1988-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.329

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.01

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,546 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,448
3-Year Documents583
Citable Documents543

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate44.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Neurology (clinical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区CRITICAL CARE MEDICINE
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Neurotrauma (abbr: J NEUROTRAUM, ISSN: 0897-7151) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 1988. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.329 (Q1), an H-index of 187.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 233 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,546 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Mary Ann Liebert Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1988
Indexing & Databases
SCIEScopusPubMed
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5de631d7-c566-439e-9fad-8da320dbfabb
Database Updated: 2026-10-01